Search research articles
Contact Us
Filters
Showing results (161-170 of 638) with videos related to
Page
of 64
Sort By:
Intensive Care Medicine
|
February 6, 2016
Dealing with phthalates in medical devices: a case of primum non nocere (first do no harm)?
Robert C Tasker, Richard M Sharpe
The Journal of Endocrinology
|
May 1, 1979
Inhibition of maturational changes in Leydig cell function after treatment of rats with an agonist of luteinizing hormone releasing hormone [proceedings]
R M Sharpe, H M Fraser
Microvascular Research
|
January 8, 2000
Aminoguanidine suppresses basal macromolecular extravasation during diabetes mellitus
W G Mayhan, G M Sharpe
Journal of Psychosomatic Research
|
September 1, 1992
The psychological treatment of patients with functional somatic symptoms: a practical guide
M Sharpe, R Peveler, R Mayou
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 28, 2002
Amnesia for childhood in patients with unexplained neurological symptoms
J Stone, M Sharpe, G Elrington
International Journal of Andrology
|
October 1, 1993
Evaluation of possible determinants and consequences of Leydig cell heterogeneity in man
S J Qureshi, R M Sharpe
FEBS Letters
|
August 5, 1996
Action of bovine serum albumin on cytochrome c oxidase activity and proton pumping: a role for fatty acids in enzyme function?
M Sharpe, I Perin, P Nicholls
Journal of Andrology
|
January 1, 1983
Leydig cell function in long-term testosterone-immunized rats
R M Sharpe, H M Fraser
Molecular and Cellular Endocrinology
|
May 1, 1980
Differences between dispersed Leydig cells and intact testes in their sensitivity to gonadotrophin-stimulation in vitro after alteration of LH-receptor numbers
R M Sharpe, A S McNeilly
Medical Biology
|
January 1, 1986
Stimulation of Leydig cell function by a polypeptide present in testicular interstitial fluid
R M Sharpe, J M Bartlett
Page
of 64
Search research articles
Search
Showing results (161-170 of 638) with videos related to
Sort By:
Page
of 64
Intensive Care Medicine
|
February 6, 2016
Dealing with phthalates in medical devices: a case of primum non nocere (first do no harm)?
Robert C Tasker, Richard M Sharpe
The Journal of Endocrinology
|
May 1, 1979
Inhibition of maturational changes in Leydig cell function after treatment of rats with an agonist of luteinizing hormone releasing hormone [proceedings]
R M Sharpe, H M Fraser
Microvascular Research
|
January 8, 2000
Aminoguanidine suppresses basal macromolecular extravasation during diabetes mellitus
W G Mayhan, G M Sharpe
Journal of Psychosomatic Research
|
September 1, 1992
The psychological treatment of patients with functional somatic symptoms: a practical guide
M Sharpe, R Peveler, R Mayou
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 28, 2002
Amnesia for childhood in patients with unexplained neurological symptoms
J Stone, M Sharpe, G Elrington
International Journal of Andrology
|
October 1, 1993
Evaluation of possible determinants and consequences of Leydig cell heterogeneity in man
S J Qureshi, R M Sharpe
FEBS Letters
|
August 5, 1996
Action of bovine serum albumin on cytochrome c oxidase activity and proton pumping: a role for fatty acids in enzyme function?
M Sharpe, I Perin, P Nicholls
Journal of Andrology
|
January 1, 1983
Leydig cell function in long-term testosterone-immunized rats
R M Sharpe, H M Fraser
Molecular and Cellular Endocrinology
|
May 1, 1980
Differences between dispersed Leydig cells and intact testes in their sensitivity to gonadotrophin-stimulation in vitro after alteration of LH-receptor numbers
R M Sharpe, A S McNeilly
Medical Biology
|
January 1, 1986
Stimulation of Leydig cell function by a polypeptide present in testicular interstitial fluid
R M Sharpe, J M Bartlett
Page
of 64